A Critical Evaluation of the Role of Subcutaneous Abatacept in the Treatment of Rheumatoid Arthritis: Patient Considerations

Biologics: Targets and Therapy - New Zealand
doi 10.2147/btt.s55783
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Reasons for Discontinuation of Subcutaneous Biologic Therapy in the Treatment of Rheumatoid Arthritis: A Patient Perspective

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2015English

Abatacept: The Evidence for Its Place in the Treatment of Rheumatoid Arthritis

Core Evidence
MedicineReviewsReferencesPharmacology
2007English

Experience With Subcutaneous Abatacept for Rheumatoid Arthritis: An Update for Clinicians

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2014English

The Efficacy and Safety of Abatacept in Rheumatoid Arthritis

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2010English

Abatacept: A T-Cell Co-Stimulation Modulator for the Treatment of Rheumatoid Arthritis

Clinical Rheumatology
MedicineRheumatology
2008English

Abatacept for the Treatment of Adults With Psoriatic Arthritis: Patient Selection and Perspectives

Psoriasis: Targets and Therapy
DermatologyRheumatology
2018English

Indomethacin in In-Patient Treatment of Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1966English

Efficacy, Safety, and Tolerability of Abatacept in the Management of Rheumatoid Arthritis

Open Access Rheumatology: Research and Reviews
Rheumatology
2009English

Surgical Treatment of the Cervical Spine in the Rheumatoid Arthritis Patient.

Orthopedics & Traumatology
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy